Pasar al contenido principal

BIOMARCADORES DE ENVEJECIMIENTO PREMATURO PREDICTORES DE CANCER NO DEFINITORIOS DE SIDA EN PERSONAS VIH QUE RECIBEN TRATAMIENTO ANTIRRETROVIRAL SUPRESOR

PID2024-157358OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Plasma biomarkers of immune regulation and senescence are associated with incident skeletal-related events in people with HIV: a case-cohort study.

  • Pita-Martínez, Carlos
  • Rava, Marta
  • Virseda-Berdices, Ana
  • Martinez, Isidoro
  • Moreno, Santiago
  • Gómez Rodríguez, Carmen Elena
  • Armiñanzas, Carlos
  • Mena de Cea, Álvaro
  • Gisbert Pérez, Laura
  • Rodríguez-Rosado, Rafael
  • Jimenez-Sousa, Maria Angeles
  • Resino, Salvador
  • Martín-Escolano, Rubén
Background: persistent immune dysregulation in people with HIV (PWH) on antiretroviral therapy (ART) contributes to an increased risk of skeletal-related events (SREs), serving as a critical paradigm for understanding accelerated aging and age-related diseases. We investigated the association between plasma biomarkers of immune regulation and senescence with incident SRE risk and evaluated potential effect modification by sex. Methods: in a case-cohort study nested within the Spanish CoRIS cohort (65 incident SRE cases; 252 subcohort, including 5 overlapping cases), we quantified 24 baseline biomarkers of immune checkpoints and senescence-associated secretory phenotype factors. We estimated adjusted hazard ratios (aHR) using Borgan II-weighted cause-specific Cox regression models adjusted for clinical confounders (age, region of origin, prior AIDS diagnosis, CD4 + T-cell count, coinfections, and lifestyle factors). Sex-biomarker interactions were assessed as exploratory endpoints. Results: nineteen biomarkers were independently associated with increased SRE risk (p < 0.05 & q < 0.10). Angiogenic factors (VEGF-A; aHR = 1.94; 95% CI, 1.40–2.68), immune checkpoints (PD-L2; aHR = 1.95; 95% CI, 1.09–3.49), and tissue remodeling markers (MMP-1; aHR = 1.91; 95% CI, 1.08–3.39) displayed independent associations, alongside consistent signals for TIM-3, PD-L1, and IL-8. Pairwise correlation analysis demonstrated clustering between checkpoints and inflammatory cytokines. Exploratory interaction analysis indicated that sex modified these associations; signals for seven markers (e.g., IL-1α, VEGF-A) were stronger in females, although the limited number of events warrants caution. Conclusions: circulating biomarkers of immune exhaustion, inflammation, and senescence are independently associated with incident SREs in PWH on long-term ART. Our findings indicate a systemic pro-inflammatory signature and suggest that females exhibit higher sensitivity to inflammatory damage.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study

  • Pita-Martínez, Carlos
  • Jiménez-Sousa, María A.
  • Martínez-Picado, Javier
  • Gómez, Carmen E.
  • Fariñas, Carmen
  • Galindo, Pepa
  • Roca-Oporto, Cristina
  • Santos, Jesús
  • Muñoz-García, Paula
  • Rava, Marta
  • Resino, Salvador
  • Martín-Escolano, Rubén
[Introduction:] People with HIV (PWH) on effective antiretroviral therapy (ART) have an increased risk of developing Non-AIDS Defining Cancers (NADCs) compared to the general population, partly due to chronic inflammation and immune dysregulation. This study aimed to identify plasma biomarkers associated with the risk of developing NADCs in a cohort of PWH on ART., [Methods:] A case-cohort study was conducted within the Spanish CoRIS cohort, including 316 PWH on ART (71 cases and 245-individuals subcohort). Plasma levels of 24 immune regulation and senescence-associated secretory phenotype (SASP) biomarkers were quantified using Luminex technology. Cox proportional hazards regression models with Borgan II weights were used to assess the association between biomarker levels and the risk of NADC development (hazard ratios), adjusting for confounders. Effect modification by gender was also evaluated., [Results:] Higher baseline plasma levels of twelve biomarkers were significantly associated with increased NADC risk. The strongest associations were found for PD–L2 (aHR=3.33), PAI–1 (aHR=2.27), and MMP–1 (aHR=2.32). However, a distinct, gender-specific pattern was observed, with significant interactions found for nine biomarkers. Most interactions indicated a higher NADC risk increase in females, with the exception of CD80, TNF–β and IP–10, which indicated a relatively lower risk in females compared to males., [Discussion:] Plasma biomarkers of immune regulation and SASP are associated with NADC risk in PWH on long-term ART, highlighting the importance of gender-specific pathways in NADC development among PWH. Understanding these distinct profiles may guide future strategies for risk stratification, early detection, and personalized preventive care., The author(s) declare financial support was received for the research and/or publication of this article. This study was supported by grants from Instituto de Salud Carlos III [(PI24CIII/00003 (SR and RME), and PI21CIII/00033 (MAJS)] and Agencia Estatal de Investigación [PID2024-157358OB-C21 (SR and RME) and PID2024-157358OB-C22 (MR and MAJS)]. The study was also funded by the CIBER -Consorcio Centro de Investigación Biomédica en Red-(CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea -NextGenerationEU (CB21/13/00044 and CB21/13/00091). RME is César Nombela researcher supported and funded by Comunidad de Madrid (grant number 2023-T1/SAL-GL-28980)., This study would not have been possible without the collaboration of all the patients, medical and nursery staff, and data managers who participated in the project. We want to acknowledge the patients in this study for their participation and the HIV BioBank integrated into the Spanish AIDS Research Network and collaborating Centers (http://hivhgmbiobank.com/donor-area/hospitals-and-centres-transferring-samples/?lang=en) for providing the clinical samples used in this work. The HIV BioBank, integrated into the Spanish AIDS Research Network, is partially funded by the RD16/0025/0019 project as part of the Plan Nacional R+D+I and cofinanced by the Instituto de Salud Carlos III (ISCIII)-FEDER., Peer reviewed